HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Schäkel Selected Research

K Schäkel Research Topics

Disease

3Psoriasis (Pustulosis Palmaris et Plantaris)
11/2023 - 06/2016
3Atopic Dermatitis (Atopic Eczema)
03/2022 - 02/2007
2Inflammation (Inflammations)
10/2023 - 06/2016
2Asthma (Bronchial Asthma)
03/2022 - 02/2007
2Eczema
06/2020 - 03/2010
2Neoplasms (Cancer)
10/2010 - 03/2010
1Rare Diseases (Rare Disease)
11/2022
1Anaphylaxis (Anaphylactic Shock)
01/2017
1Hypersensitivity (Allergy)
01/2017
1Pruritus (Itching)
03/2013
1Chronic Urticaria
03/2013
1Urticaria (Hives)
03/2013
1Dyshidrotic Eczema (Pompholyx)
10/2010
1Skin Diseases (Skin Disease)
03/2010
1Skin Neoplasms (Skin Cancer)
03/2010
1Actinic Keratosis
03/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2010
1Basal Cell Carcinoma (Rodent Ulcer)
03/2010
1Infections
05/2008
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2008
1Autoimmune Diseases (Autoimmune Disease)
05/2008
1Vascular Diseases (Vascular Disease)
05/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2003
1Blast Crisis (Blast Phase)
05/2003

Drug/Important Bio-Agent (IBA)

2guselkumabIBA
11/2023 - 10/2023
2Immunoglobulin E (IgE)IBA
03/2022 - 02/2007
1InterleukinsIBA
10/2023
1Prostaglandins AIBA
03/2022
1Immunoglobulin A (IgA)IBA
06/2020
1dupilumabIBA
01/2020
1Arthropod VenomsIBA
01/2017
1AllergensIBA
01/2017
1CytokinesIBA
06/2016
1miltefosine (Impavido)IBA
03/2013
1Histamine Antagonists (Antihistamines)IBA
03/2013
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2010
1MTOR InhibitorsIBA
03/2010
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2010
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2010
1Indicators and Reagents (Reagents)IBA
03/2010
1Prednisolone (Predate)FDA LinkGeneric
03/2010
1RetinoidsIBA
03/2010
1CryoglobulinsIBA
05/2008
1AutoantibodiesIBA
05/2008
1Antigen-Antibody Complex (Immune Complex)IBA
05/2008
1AntibodiesIBA
05/2008
1CollagenIBA
05/2008
1Omalizumab (Xolair)FDA Link
02/2007
1anti-IgE antibodiesIBA
02/2007
1Imatinib Mesylate (Gleevec)FDA Link
05/2003

Therapy/Procedure

3Therapeutics
11/2022 - 03/2010
1Transplantation
03/2010
1Chemoprevention
03/2010
1Organ Transplantation
03/2010
1Secondary Prevention
03/2010